ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 676184 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 676184; 2) Community: the network communities that were significantly associated with the response to NSC 676184; 3) Molecule: the relationships between components within communities and NSC 676184; 4) MDR: the compounds that were significantly associated with the NSC 676184.

NSC Compound Enrichment Correlation
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.0312262198176281 0.062265938
NSC 294980 N,N-Bis(2-chloroethyl)-p-toluidine 0.0312262198176281 0.0014161817
NSC 364830 Camptothecin Derivative 0.0312262198176281 0.056850781
NSC 407806 .delta.20:22-3,14,21-Trihydroxynorcholenic acid lactone 0.0312262198176281 0.034378317
NSC 4320 .beta.-k-Strophanthin 0.0312262198176281 -0.13682005
NSC 614383 Null 0.0312262198176281 -0.027197069
NSC 636092 Pyridine-3,5-dicarboxamide, 1,4-dihydro-2,6-dimethyl- 4-[4-(dimethylamino)phenyl]-N,N'-diphenyl- 0.0312262198176281 0.16555826
NSC 638487 (Z) 4-Acetoxy-(3,4',5)-trimethoxystilbene 0.0312262198176281 0.0269123
NSC 648365 Insulin-Methotrexate conjugate 0.0312262198176281 0.22437921
NSC 657751 Null 0.0312262198176281 0.32320837
Total:44  Current:29    [First] [Prev] [Next] [Last]